BSR KOREA Introduces “CORE VALUE” as “2022 Global Procurement Marketer”
SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the international procurement market, including capacity building training programs, overseas vendor registration, and...
Aloe Vera of America Receives Award for Environmental Health Efforts
For the eighth consecutive year, the aloe vera product manufacturer and distributor was given the Blue Thumb Award DALLAS, Dec. 6, 2022 /PRNewswire/ -- Aloe Vera of America, Inc. the Dallas-based manufacturer and distributor of Forever Living's aloe vera-based products to over 160 countries, recently received the Blue Thumb Award for its continued commitment to environmental compliance. ...
Neeuro and Institute of Mental Health Launch Home-Based Attention Training Programme
SINGAPORE, Dec. 6, 2022 /PRNewswire/ -- Neeuro, a Singapore tech start-up and Agency for Science, Technology and Research (A*STAR) spinoff, and the Institute of Mental Health (IMH) launched Cogo as a complementary home-based attention training programme this month. This solution aims to improve inattentiveness in children aged 6 to 12 years through a 24-session guided game that is paired...
SK Biopharmaceuticals Wins Export Award for Cenobamate
SK Biopharmaceuticals receives the '$100 million Export Tower' award, becoming the first Korean pharma company to earn this prestige with a single innovative anti-seizure medication, cenobamate Cenobamate achieves over $100 million in exports in two years after launching in the U.S. and Europe – the world's two biggest pharmaceutical markets PANGYO, South Korea,...
Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors
YANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the appointments of Mr. Xin Wang as Chief Executive Officer and director, Mr. Lianzhang Zhao as Chief Financial Officer...
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project
HAIKOU, China, Dec. 5, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the Acquisition of Dry Eye Disease Therapeutic Device Project. This device has a patent Epidemiological research shows that the incidence rate of DED...
Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine®
HAMBURG, Germany, Dec. 5, 2022 /PRNewswire/ -- apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine®, a pioneering mixed reality software device enabling surgeons to plan complex procedures using the power of immersive 3D holographic technology. With this clearance, the USA becomes...
Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform
SHANGHAI, Dec. 5, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that after three years of preparation, the Company's MDMOOC platform has established a "Surgical-Interventional-Drug" ("SID") platform for liver cancer comprehensive-disciplinary physician education ("SID Platform"), providing physicians with knowledge...
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp
NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") (Nasdaq: IRAA), a publicly traded special purpose acquisition company ("SPAC") formed for the purpose of acquiring or merging with one or more businesses, announced they...
The First IBCC Unveiled in Hainan
SHANGHAI, Dec. 5, 2022 /PRNewswire/ -- The first Integrated Bladder Cancer Center (IBCC) in Hainan Province was inaugurated in Hainan General Hospital at the Hainan Provincial Urology Annual Meeting. A patient-centered facility, the IBCC serves to improve inpatient experiences as well as medical service efficiency through a full-course management model. Gao Xinpu, Director of the Medical Administration Bureau of...
